SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-235585
Filing Date
2020-08-31
Accepted
2020-08-31 08:23:34
Documents
13
Period of Report
2020-08-27
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d56569d8k.htm   iXBRL 8-K 27947
2 EX-99.1 d56569dex991.htm EX-99.1 6012
  Complete submission text file 0001193125-20-235585.txt   157133

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA agen-20200827.xsd EX-101.SCH 3073
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE agen-20200827_lab.xml EX-101.LAB 17374
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE agen-20200827_pre.xml EX-101.PRE 10955
6 EXTRACTED XBRL INSTANCE DOCUMENT d56569d8k_htm.xml XML 3303
Mailing Address 3 FORBES ROAD LEXINGTON MA 02421
Business Address 3 FORBES ROAD LEXINGTON MA 02421 781-674-4410
AGENUS INC (Filer) CIK: 0001098972 (see all company filings)

IRS No.: 061562417 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-29089 | Film No.: 201149903
SIC: 2836 Biological Products, (No Diagnostic Substances)